Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00253682 · ClinicalTrials.gov registry record
Effects of Highly Active Anti-Retroviral Therapy on Cardiovascular Health in Infants of HIV-Infected Mothers
A clinical trial of HIV Infections and Cardiovascular Diseases, sponsored by University of Miami.
- Completed
- Registry status
- 167
- Enrollment target
- 5
- Study locations
NCT00253682 is a study of HIV Infections and Cardiovascular Diseases that has completed, run by University of Miami. The registered enrollment target is 167 participants, below the 446-participant average among 542 other HIV Infections trials with a reported enrollment target (63% lower). The trial reports 5 study locations across 5 states.
The verdict
NCT00253682, a study of HIV Infections and Cardiovascular Diseases, has completed, sponsored by University of Miami.
- COMPLETED
- Registry status
- 167 participants
- Enrollment target
- 5
- Study locations
Study Summary
This study will determine the impact of highly active antiretroviral therapy (HAART) on the developing cardiovascular system, the evolution of HAART-associated cardiovascular changes over time, and the association between cardiovascular measurements with HAART exposure.
Conditions Studied
Study Locations (5)
Florida
- University of Miami School of Medicine - Miami
Illinois
- University of Illinois - Chicago - Chicago
Massachusetts
- Boston Medical Center - Boston
New York
- Columbia University - New York
Texas
- Baylor College of Medicine - Houston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 167 participants |
| Start Date | 2002-09 |
| Est. Completion | 2006-12 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00253682
The ClinicalTrials.gov registry entry for NCT00253682 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 167 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 446-participant average among 542 other HIV Infections trials with a reported enrollment target (63% lower). The listed sponsor is University of Miami, which has 721 total studies on file at ClinicalTrials.gov.
The record links to 5 conditions, with HIV Infections appearing as the primary indexed condition, and to 0 interventions.
NCT00253682 reports 5 study locations spanning 5 distinct geographic areas - top geographies include Florida, Illinois, Massachusetts.
Frequently Asked Questions
What is clinical trial NCT00253682 about?
NCT00253682 is a clinical study titled "Effects of Highly Active Anti-Retroviral Therapy on Cardiovascular Health in Infants of HIV-Infected Mothers". This study will determine the impact of highly active antiretroviral therapy (HAART) on the developing cardiovascular system, the evolution of HAART-associated cardiovascular changes over time, and the association between cardiovascular measurements with HAART exposure.
What is the current status of trial NCT00253682?
This trial is currently completed. The enrollment target is 167 participants. The study started on 2002-09. Estimated completion is 2006-12.
What conditions does trial NCT00253682 study?
This clinical trial studies the following conditions: HIV Infections, Cardiovascular Diseases, Heart Diseases, Atherosclerosis, Cardiomyopathy, Hypertrophic.
Who is sponsoring clinical trial NCT00253682?
This trial is sponsored by University of Miami, which has 721 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00253682 being conducted?
This trial has 5 study locations across Florida, Illinois, Massachusetts, New York, Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for HIV Infections
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
TRAC-ER Intervention to Reduce Risky Alcohol Use and HIV Risk
RECRUITING · NA
-
Community-based Education, Navigation, and Support Intervention for Military Veterans
RECRUITING · NA
-
CAR-T Cells for HIV Infection
RECRUITING · Phase 1
-
A Study to Investigate the Use of VH3810109 With or Without Fostemsavir (FTR) to Reduce the Size and Activity of the Viral Reservoir in People Living With HIV
RECRUITING · Phase 1
-
WiseApp for Spanish Speakers Living With HIV
RECRUITING · NA
-
Comprehensive HIV and Harm Prevention Via Telehealth
RECRUITING · NA
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.